A Randomized, Open Label, Comparative, Multi-center Clinical Trial to Determine the Efficacy and Safety of Topiramate Comparing With Carbamazepine in Benign Rolandic Epilepsy.
Sponsor study identifier
interventional
114
0 countries
N/A
Study Start
December 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
February 2006
Actual (reported)The purpose of this study is to determine the efficacy and safety of Topiramate in comparison to Carbamazepine in Benign rolandic epilepsy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2006
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2002
Date type not reportedThis date has not been verified as actual or estimated.
September 13, 2005
Actual (reported)September 22, 2005
Actual (reported)February 2006
Actual (reported)Seizure-free rate at 24 weeks in comparison of topiramate to carbamazepine
In comparison of topiramate to carbamazepine, Intellectual Functioning : KEDI-WISC (Korean Educational Development Institute Wechsler Intelligence Scale for Children-Revised)
Janssen Korea, Ltd. Clinical Trial
Janssen Korea, Ltd.
114 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2005
First Posted
September 22, 2005
Study Start
December 2002
Date type not reportedThis date has not been verified as actual or estimated.
A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians
Contact the study team to confirm eligibility.
Study Completion
February 2006
Actual (reported)Last Updated
February 1, 2011
Record last verified: 2011-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: